CA
NZ
UK
AU
IND
US
Cosmos Health Inc. (NASDAQ: COSM) is a healthcare company that occupies an unusual position in the penny-stock landscape: it trades below $1 yet generates tens of millions of dollars in annual revenue. That combination — a micro-cap valuation on a business with real, growing …
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) is a clinical-stage biotechnology company developing oncology virotherapies — engineered viruses designed to attack tumours and stimulate anti-cancer immune responses. The science targets a meaningful area of cancer research, but the company trades below $1, carries going-concern risk, …
Accuray Incorporated (NASDAQ: ARAY) is an established medical-device company that has slipped into penny-stock territory despite operating a substantial, revenue-generating business in radiation oncology. Unlike many sub-$1 stocks built on concepts or crypto narratives, Accuray sells sophisticated cancer-treatment systems to hospitals and clinics worldwide …
Autonomix Medical, Inc. (NASDAQ: AMIX) is a clinical-stage medical-technology company developing a catheter-based platform aimed at sensing and treating nerves, with an initial focus on relieving pain in patients with pancreatic cancer. Its technology targets a serious unmet need, and the company has reported …
Aditxt, Inc. (NASDAQ: ADTX) is a life-sciences holding company that has become one of the most extreme examples of penny-stock dilution and reverse-split activity in the market. The company pursues health-focused ventures across immune health and related areas, but its share-price history has been …
Biosimilars Strategy Strengthens Long-Term Growth Outlook
Middle East Tensions Support Energy Stocks
Investors Welcome Strong Post-Merger Production Outlook
Energy Market Sentiment Supports Natural Gas Stocks
Strong NXC-201 Clinical Data Drives Investor Interest
Please wait processing your request...